Biolab is a brazilian pharmaceutical company, focused on prescription drugs, leader in cardiology and dermatology sales in the country, interested in partnering and in-licensing opportunities, of both late-stage projects and marketed products.
Over 100 products on the market specially focused in cardiovascular diseases, gynecology, dermatology, rheumatology, orthopedics, pediatrics, endocrinology, geriatrics and GP.
Absolut leader on Cardiovascular drugs market in Brazil, reaching 1st place on dermatology since recent years.
The revenue estimate for 2019 is R$ (BRL) 2,2 billion (around USD 600 MM) on sales. Its sales force has more than 1.400 collaborators fully dedicated to promoting company's portfolio all over the Brazilian territory.